Study the Effect of Oral Zinc Supplementation on Enzymes of Nitric Oxide Pathway

Sponsor
Babylon University (Other)
Overall Status
Completed
CT.gov ID
NCT01684059
Collaborator
Ministry of Health, Iraq (Other)
60
1
12
5

Study Details

Study Description

Brief Summary

The ability of spermatozoa to produce reactive oxygen species (ROS) has been respected since the 1940's. Oxidative stress limits the functional competence of mammalian spermatozoa via lipid peroxidation, the induction of oxidative DNA damage and the formation of protein adducts. Nitric oxide (NO) is a free radical generated from the oxidation of L-arginine to L-citrulline by reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent NO synthases. Several studies suggest that the overproduction of this free radical and the subsequent excessive exposure to oxidative conditions have a potential pathogenetic implication, which due to the reduction of sperm motility. The present study was conducted to study the effect of Zn supplementation on the levels of NO synthase and arginase in semen of patients with asthenozoospmia.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: zinc sulfate

Detailed Description

Previous studies suggest that high concentrations of NO play an injurious consequence on spermatozoa kinetic characteristics. These studies reported that NO may react with superoxide or hydrogen peroxide, resulting in the production of peroxinitrite, hydroxyl radical, or singlet oxygen, which cause oxidation of sperm membrane lipids and thiol proteins. NO also may inhibit cellular respiration by nitro-sylation of heme in mitochondrial enzymes, aconitase, and glyceraldehyde phosphate dehydrogenase, leading to a reduction of adenosine triphosphate and that is due to loss of motility of spermatozoa.

Study Design

Study Type:
Observational
Actual Enrollment :
60 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Study the Effect of Oral Zinc Supplementation on Enzymes of Nitric Oxide Pathway
Study Start Date :
Jul 1, 2011
Actual Primary Completion Date :
Jul 1, 2012
Actual Study Completion Date :
Jul 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Single group

Single group: each participant receive same intervention (zinc sulfate) throughout study (non-randomized)

Dietary Supplement: zinc sulfate
every participant took two capsules of zinc sulfate per day for three months (each one 220mg)

Outcome Measures

Primary Outcome Measures

  1. Nitric oxide synthase activity [at the end of three months]

Secondary Outcome Measures

  1. Arginase activity [at the end of three months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
27 Years to 35 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • the presence of asthenozoospermia in the semen sample.
Exclusion Criteria:
  • the absence of endocrinopathy,

  • varicocele, and

  • female factor infertility. Smokers and alcoholic men were excluded from the study because of their recognized high seminal ROS levels and decreased antioxidant levels

Contacts and Locations

Locations

Site City State Country Postal Code
1 Babylon university/ college of science Hilla Iraq IQ

Sponsors and Collaborators

  • Babylon University
  • Ministry of Health, Iraq

Investigators

  • Principal Investigator: mahmoud H. hadwan, phD, babylon university / Iraq
  • Study Chair: Lamia A. Almashhedy, phD, Babylon university/Iraq
  • Study Director: abdulrrazaq S. Alsalman, phD, Babylon university/Iraq

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
mahmoud hussein hadwan, phD, Babylon University
ClinicalTrials.gov Identifier:
NCT01684059
Other Study ID Numbers:
  • Babil-2
First Posted:
Sep 12, 2012
Last Update Posted:
Sep 12, 2012
Last Verified:
Sep 1, 2012
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 12, 2012